Innovating Works

Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe

Activa
Mostrando 1 al 20 de 29 resultados
NATPRIME: Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers TECHNISCHE UNIVERSITEIT EINDHOVEN tramitó un HORIZON EUROPE: Delivery of Nucleic Acid Therapeutics to desired organs has become the current challenge of biotechnological applications. Advancements on t...
2024-07-10 - 2028-09-30 | Financiado
UNLOOC: Unlocking data content of Organ On Chips The launch of a novel drug to the market is preceded by clinical testing and validation both on animal in vitro and in vivo models. Animal m...
2024-06-28 - 2027-04-30 | Financiado
REGUBIOME: Transcriptional REGUlation as a mediator of bacterial interactions in the microBIOME Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un HORIZON EUROPE: ERC-2023-STG Bacteria from the gut microbiota constantly interact with a range of abiotic and biotic factors. Perturbations in these factors, such as nut...
2023-09-18 - 2028-10-31 | Financiado
TherACCage: Therapeutic Artificial Cells based on Molecular Cages for Glioblastoma Treatment UNIVERSITAT POLITÈCNICA DE VALÈNCIA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Cancer is still a major societal challenge, as reflected by the Horizon's Europe mission on cancer and the Europe's Beating Cancer Plan. In...
2022-06-21 - 2025-08-31 | Financiado
POLYBRAINT: Versatile Polypeptide-based Intranasal Drug Delivery Platform(s) to Tackle CNS Disorders. Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un HORIZON EUROPE: ERC-2022-POC1 Nearly one in six of the world's population suffered from neurological disorders, this number is expected to keep growing. Many of those cen...
2022-05-31 - 2023-11-30 | Financiado
RISEUP: Regeneration of Injured Spinal cord by Electro pUlsed bio hybrid imPlant AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE LENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE tramitó un H2020: H2020-FETOPEN-2018-2020 Spinal Cord Injury (SCI), a major cause of paralysis, currently has no effective therapies. Every year almost 500.000 people are diagnosed w...
2020-12-21 - 2025-04-30 | Financiado
BIOMOLMACS: Molecular Machines Functioning in Cells UNIVERSITY OF WARWICK tramitó un H2020: H2020-MSCA-ITN-2019 The main motivation of BIOMOLMACS training network is to establish a multidisciplinary training network on the emerging topic of molecular m...
2019-09-11 - 2024-06-30 | Financiado
EU-OPENSCREEN-DRIVE: Ensuring long term sustainability of excellence in chemical biology within Europe and beyond ALL EUROPEAN ACADEMIES (ALLEA) e.V. tramitó un H2020: H2020-INFRADEV-2018-2020 EU-OPENSCREEN (EU-OS), the European Research Infrastructure of Open Screening Platforms for Chemical Biology, builds a distributed organizat...
2018-12-13 - 2023-10-31 | Financiado
POLYMMUNE: Off the Shelf Polypeptide based Immunotherapy for Advanced Melanoma Treatment Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un H2020: ERC-2018-PoC Despite various existing drug delivery methods, the key challenge remains: how to deliver drugs to the desired site of therapeutic action to...
2018-12-07 - 2020-09-30 | Financiado
EPIC: Exploiting Protein Complexes that Induce Cell death UNIVERSITY OF GALWAY tramitó un H2020: H2020-MSCA-RISE-2015 The formation of specific protein complexes are key events in life-and-death decisions made by cells. Inappropriate decisions underpin a ple...
2015-12-21 - 2019-12-31 | Financiado
StemBAT: New players in human BAT differentiation and activation a human PSC derived BAT approach combined w... THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE tramitó un H2020: ERC-2014-ADG Here we propose a strategy to control body weight and prevent/reverse obesity based on targeting brown adipose tissue (BAT) to facilitate ne...
2015-12-08 - 2023-12-31 | Financiado
ELIXIR-EXCELERATE: ELIXIR EXCELERATE Fast track ELIXIR implementation and drive early user exploitation across the lif... EUROPEAN MOLECULAR BIOLOGY LABORATORY tramitó un H2020: H2020-INFRADEV-2014-2015 The life sciences are undergoing a transformation. Modern experimental tools study the molecules, reactions, and organisation of life in unp...
2015-08-11 - 2019-08-31 | Financiado
MyNano: Towards the design of Personalised Polymer based Combination Nanomedicines for Advanced Stage Breast... Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un H2020: ERC-2014-CoG Research on anticancer therapies has provided little progress towards improved survival rates for patients with metastatic disease. The intr...
2015-05-05 - 2020-12-31 | Financiado
DEANN: Developing an European American NGS Network Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un FP7: The DEANN project is a network formation initiative that involves six research institutions and universities from four EU countries and equi...
Financiado
HESC METABONOMICS: Elucidation of Stem Cell Fate and Cell type Characterization by 1H NMR based Metabonomics Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un FP7: Human Embryonic Stem Cells (hESCs) harbour the extraordinary ability to self-renew and differentiate into cells of all tissue types and thus...
Financiado
STATegra: User driven Development of Statistical Methods for Experimental Planning Data Gathering and Integr... Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe tramitó un FP7: Users of NGS technologies, producing large and numerous distinct types of omics data, demands statistical methods to combat data and knowled...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.